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Abstract 
 
Purpose:  
The minimally invasive treatment of ureteropelvic junction obstruction has evolved during 
the last decade from endoscopic to laparoscopic and robotic. We review our 10-year 
experience with ureteropelvic junction obstruction, and report on our experience and 
followup.  
 
Materials and Methods:  
We reviewed all patients treated during the last 10 years. There were 294 procedures 
performed with complete records on 273 patients including 128 retrograde 
endopyelotomies, 116 laparoscopic pyeloplasties and 29 robotic pyeloplasties. Technique 
for each procedure is reviewed. Statistical analysis was performed on all results. Variables 
evaluated were gender, age (younger than 41 vs 41 years or older), side (right or left), 
presence of crossing vessels, presence of a high insertion, primary or secondary procedure 
and whether prior endopyelotomy or pyeloplasty had been performed.  
 
Results:  
Mean followup for endopyelotomy, laparoscopic pyeloplasty and robotic pyeloplasty was 
20, 20 and 19 months, respectively, with success rates of 60.2%, 88.8% and 100%, 
respectively. On univariable analysis only the presence of crossing vessels or a high 
insertion was significant for laparoscopic pyeloplasty. On multivariable analysis age was 
significant for endopyelotomy and the presence of crossing vessels was significant for 
pyeloplasty. On Kaplan-Meier analysis failures were noted to occur after 5 years in both 
groups.  
 
Conclusions:  
Laparoscopic pyeloplasty and robotic pyeloplasty are superior minimally invasive 
treatments for ureteropelvic junction obstruction. However, endopyelotomy can be used for 
select patients. Because of late failures patients who undergo either of these procedures 
should receive long-term followup.  
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In the last decade open pyeloplasty has largely been replaced by minimally invasive 
approaches for the treatment of ureteropelvic junction obstruction in adults. In the 1980s 
antegrade endopyelotomy by cold knife performed through a nephrostomy tract was first 
reported.
1 
This technique offered the advantage of being able to treat considerable renal 
calculus burdens during the same procedure. However, it requires the establishment of a 
nephrostomy tract before the endopyelotomy can be performed as well as longer hospital 
stays. Ureteroscopic endopyelotomy soon followed, initially described as pyelolysis using 
the rigid ureteroscope.
2 
It was difficult to reach the ureteropelvic junction with a rigid 
ureteroscope and the availability of flexible instruments prompted the wider acceptance of 
flexible ureteroscopic endopyelotomy.
3 
 
Since the first published reports in 1993 laparoscopic pyeloplasty has proven to be safe 
and effective with outcomes comparable to the open procedure and superior to 
endopyelotomy.
4–6  
One drawback has been the relatively steep learning curve for this 
procedure. In particular, intra-corporeal suturing with laparoscopic instruments can be 
technically demanding.  
The da Vinci® Surgical System has enabled these laparoscopic techniques to be 
performed with greater ease and, in the process, has expanded the use of laparoscopy in 
urology. The known advantages of the robotic system to the surgeon allow for more 
efficient intracorporeal suturing. This has led to shorter operative times with similar 
success rates compared to the straight laparoscopic approach.
7,8  
We present our experience 
with the minimally invasive treatment and long-term followup of UPJO.  
 
MATERIALS AND METHODS  
 
After institutional review board approval charts of all patients treated for UPJO at our 
institution from 1995 to 2006 were retrospectively reviewed. A total of 294 patients 
underwent minimally invasive treatment. The initial diagnosis of UPJO was based on 
subjective criteria such as flank pain and pyelonephritis or incidental findings from 
radiological evaluation of unrelated medical conditions. Radiological verification was 
obtained by excretory urography or CT urography. In addition, all patients had preoperative 
diuretic renogram to establish baseline renal function including split renal function and the 
degree of obstruction. Evaluation for crossing vessels was performed by CT angiogram or 
endoluminal ultrasound. For patients undergoing pyeloplasty indwelling stents were 
removed 2 to 3 weeks before the procedure. It is our belief that indwelling stents increase 
edema and UPJ wall thickening, making for a more difficult dissection and reconstruction 
of the UPJ.  
 
Our technique of endopyelotomy has been described previously.
9 
We begin with a 
retrograde pyelogram which demonstrates the length of the UPJ narrowing and identifies 
any additional ureteral strictures. This is followed by endoluminal ultrasound using a 6Fr 
probe. We can identify the presence of crossing vessels noting their size and location as 
well as a septum which indicates a high ureteral insertion into the UPJ.
10,11 
After placement 
of a safety wire a flexible ureteroscope is introduced and the UPJ is visualized. The 
information collected from these imaging studies determines the site and length of the 
incision. Endopyelotomies early in our series were performed using a small diameter 
electrode, but this has largely been replaced by the 200 micron holmium laser fiber with 
preferred energy and frequency settings of 1.2 to 1.5 Joules per pulse and 10 to 15 Hertz, 
respectively. The incision is made through the entire thickness of the ureter. Finally a 
balloon catheter is deployed to calibrate the incision and open the adventitia. A ureteral 
stent is then placed which is removed approximately 6 to 8 weeks after surgery.  
 
 
Positioning and exposure for LP and RP are essentially the same. The patient is 
positioned in a modified 45-degree flank position. Cystoscopy is performed to pass a 
guidewire into the proximal ureter for later stent placement. A standard 4 trocar 
arrangement is used which includes a 12 mm periumbilical trocar for the laparoscope 
anda5mm assistant trocar. LP uses a pair of 5 mm working trocars while RP replaces these 
with a pair of 8 mm da Vinci trocars. Dissection begins with medial reflection of the colon 
and is followed by isolation of the ureter at a location inferior to the lower pole of the 
kidney. The ureter is mobilized, and traced up to the UPJ and renal pelvis. If present, 
crossing vessels are identified and preserved. Once the UPJ is fully dissected 
dismemberment is performed and the affected segment is resected. Crossing vessels are 
repositioned posterior to the anastomosis and after ureteral spatulation the anastomosis is 
completed using 4-zero polyglactin sutures over an indwelling ureteral stent. The stent 
remains in place for 6 weeks.  
 
 
Currently for all patients a diuretic renogram is performed at 3 and 6 months, and 1 year 
postoperatively. Additionally, if the initial renogram is normal an ultrasound is 
occasionally used afterward if the patient remains asymptomatic. A renal ultrasound or 
diuretic renogram is also obtained annually thereafter. Successful repair is defined as 
resolution of preoperative symptoms and improvement or stability of radiographic 
parameters. When we evaluate our patients using t½ criteria success is defined with t½ less 
than 10 minutes (strict success) or 10 to 20 minutes (relative success). When the renogram 
demonstrates delayed drainage (more than 20 minutes) but shows relative improvement in 
the t½ compared to preoperative values, as long as the patient remains asymptomatic and 
the split function improves or stays stable, then the repair is also considered patent. 
Alternatively if the t½ demonstrates relative success (10 to 20 minutes) and the patient has 
a relapse of symptoms and a decline in function by diuretic renogram, the repair is 
considered a failure. Cox regression hazard ratios and Kaplan-Meier failure-free estimates 
were determined for the endopyelotomy and LP populations. 
 
 
RESULTS  
 
We reviewed 145 retrograde endopyelotomies, 120 LPs and 29 robotic assisted 
laparoscopic pyeloplasties (RPs) with followup available on 128 (88.3%), 116 (96.7%) and 
29 (100%), respectively. Patient characteristics of each group with followup are presented 
in table 1. The number of each procedure performed by year is presented in figure 1. 
Median followup (range) for the endopyelotomy, LP and RP groups was 20 (1 to 165), 20 
(1 to 87) and 19 (13 to 25) months, respectively. The overall success rate for the 
endopyelotomy group was 60.2% and for the LP group was 88.8%. There have yet to be 
failures in the RP group. Univariable and multivariable analysis is presented in table 2. On 
univariable analysis there was no difference in success for the endopyelotomy group when 
examining sex, presence of crossing vessels or high insertion, primary vs secondary repair, 
side or age. In the LP group the only statistically significant differences on univariable 
analysis were for the presence of crossing vessels and high insertion (p = 0.028 for each). 
On multivariable analysis undergoing LP was statistically significant (p <0.001) as was age 
41 years or older (p = 0.003). In the endopyelotomy group age was the only significant 
variable (p = 0.014) while the presence of crossing vessels was the only significant variable 
in the LP group (p = 0.028). Kaplan-Meier 1, 3 and 7-year failure-free estimates for 
endopyelotomy were 82%, 62% and 50%, and for LP were 93%, 86% and 76%, 
respectively (p <0.001) (fig. 2). In the RP group 31% of the repairs were for secondary 
UPJO and 20 patients overall were found to have crossing vessels. Because of shorter 
followup these patients were not included in the statistical analysis.  
 
 
DISCUSSION  
 
We found the success rate for LP to be significantly greater than for endopyelotomy. 
However, while a majority of treatment failures occurred within the first 2 years for both 
groups there were still failures as followup continued. As a result success rates were lower 
than has generally been described, in part because many studies have short 1 to 2-year 
followup.
4,5,12 
Our findings are notably similar to those of Dimarco et al, who found 
estimated 3, 5 and 10-year recurrence-free survival rates for endopyelotomy to be 63%, 
55% and 41%, respectively, compared to 85%, 80% and 75% for pyeloplasty (p <0.001) 
(fig. 3).13  
 
 
The implications of these findings are far-reaching. For endopyelotomy and pyeloplasty 
we contend that patients should have long-term followup, which is contradictory to what 
has been recommended in the past.
14,15 
In addition, we have changed our followup for 
endopyelotomy and pyeloplasty to be more consistent with our findings. Although we still 
see patients every 3 to 6 months in the year after treatment with a functional study, we now 
see them annually thereafter with renal ultrasound and diuretic renogram, if needed, to 
evaluate for new hydronephrosis, cortical loss or return of symptoms. When evaluating t½ 
we consider relative improvement in addition to strict (less than 10 minutes) and relative 
(10 to 20 minutes) success. There were 2 patients in the endopyelotomy group and 1 in the 
pyeloplasty group who had a t½ that was persistently more than 20 minutes after repair. In 
all 3 patients this represented an improvement compared to preoperative values and the 
patients remained asymptomatic with stable differential function. These repairs were 
regarded as successful. Alternatively 1 patient in each group had a t½ that was 10 to 20 
minutes after repair but had a postoperative return of symptoms and a decline in renal 
function. Although the t½ showed relative success, both of these cases were considered 
failures.  
 
 
Our identification of long-term failures is especially relevant for the RP group, in which 
no failures have been recognized with relatively short followup. All of these patients have 
demonstrated strict or relative success by postoperative t½ values. However, based on the 
previously mentioned failure-free estimates it would not be unreasonable to expect failures 
as surveillance continues.  
On multivariable analysis the presence of crossing vessels led to a statistically significant 
improvement in success in the LP group. Because of prior experience we did not treat these 
patients with endopyelotomy, thus selecting out those at high risk for failure.
10 
An 
explanation for the statistical significance in LP could be that crossing vessels provide a 
definitive target for repair. This would allow for pinpoint identification and reconstruction 
of the affected area leading to improved success rates. We routinely transpose any lower 
pole crossing vessels lateral to our repair, although the necessity of this has recently been 
called into question.
16 
Regardless of this controversy, like others we contend that crossing 
vessels, when present, represent a clear etiology of obstruction that needs to be addressed 
for a repair to be successful.
17,18 
In addition, we found that age younger than 41 years was 
significant for success in endopyelotomy. However, this was not the case for the LP group. 
When considering treatment options with respect to age we choose LP for younger patients 
because of better long-term success. Other variables that we did not evaluate which likely 
would have also proved significant and have also been recognized by other groups are 
severe hydronephrosis and preoperative renal function.
12,19,20  
 
 
Other single institution comparisons of endopyelotomy and pyeloplasty for UPJO have 
been made.
12,13,19 
However, in 2 of these reports antegrade endopyelotomy was the 
endoscopic method used.
12,13 
In the series by Rassweiler et al laser endopyelotomy was 
used with a success rate of 78.3%.
19 
However, their Kaplan-Meier estimation of success 
included a time course that extended out to half of what we reported. Arguably with longer 
followup they would have realized more failures and they actually concluded at the end of 
their study that, even with careful patient selection, endopyelotomy was inferior to 
pyeloplasty in direct comparison. Our series, to our knowledge the largest reported with 
long followup, confirms this conclusion. This can be inferred from our practice patterns 
during the last decade (fig. 1). Currently the only patients for whom we are recommending 
endopyelotomy primarily are those who have an absence of crossing vessels and severe 
hydronephrosis (detected intraoperatively by endoluminal ultrasound and retrograde 
pyelogram, respectively), and who are otherwise poor surgical candidates or refuse a more 
invasive procedure. Still, with low morbidity and high success rates pyeloplasty 
(laparoscopic or robotic) is the definitive minimally invasive procedure for UPJO, and any 
patient younger than 40 years with salvageable renal function, regardless of UPJ pathology, 
is treated with either of these operations at our institution. Other putative benefits of LP/RP 
include the ability to treat patients with UPJO with aberrant anatomy, different degrees of 
hydronephrosis or concomitant calculi. Furthermore, with the advent of robotic technology, 
which may not add anything to LP in experienced hands but will help to disseminate it 
among less skilled urologists, the procedure will become more widespread. At our 
institution the decision between LP and RP is surgeon dependent, and is not influenced by 
individual patient or pathological considerations. 
 
CONCLUSIONS  
 
While laparoscopic pyeloplasty continues to have significantly improved outcomes 
compared to endopyelotomy, anticipated rates of success appear to be less than previously 
reported. It is clear that remote failures do occur in both groups and, therefore, these 
patients should be continually followed. However, with long-term followup pyeloplasty 
remains superior. The presence of crossing vessels is a positive predictor for patients who 
undergo pyeloplasty and patients with this UPJ pathology should be treated with this 
procedure. Finally robotic pyeloplasty parallels the success of LP and will likely make this 
procedure more common, thus further minimizing the role of endopyelotomy.  
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ABBREVIATIONS AND ACRONYMS  
CT = computerized tomography 
LP = laparoscopic pyeloplasty 
RP = robotic pyeloplasty 
t½ = half-time 
  UPJ = ureteropelvic junction  
    UPJO = ureteropelvic junction obstruction  
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Figures and Tables 
 
FIG. 1.  
Practice patterns for treatment of UPJO during last decade. Cases from 2007 not included 
in statistical analysis. 
 
 
FIG. 2.   
Kaplan-Meier estimates of failure-free probability for endopyelotomy and laparoscopic 
pyeloplasty.  
 
 
 
FIG. 3.  
 
Comparative success rates of endopyelotomy and laparoscopic pyeloplasty. Solid line 
indicates findings of Dimarco et al.
13 
Broken line indicates findings of current study.  
 
 
 
  
 
TABLE 1.   Patient characteristics 
                                                                                                           No. (%) 
 Endopyelotomy  LP  RP  Totals  
Total pts  128  116  29  273  
Sex:      
     Male  46 (35.9)  50 (44.2)  11 (37.9)  107 (39.1)  
     Female  82 (64.1)  66 (58.4)  18 (62.1)  166 (60.9)  
Crossing vessels:*      
     Yes  52 (40.6)  80 (70.2)  20 (69.0)  152 (56.1)  
     No  76 (59.4)  34 (29.8)  9 (31.0)  119 (45.9)  
High insertion:†      
     Yes  78 (60.9)  18 (30.5)  Not available  96 (51.3)  
     No  50 (39.1)  41 (69.5)  Not available  91 (48.7)  
Repair:      
     Primary  91 (71.1)  84 (72.4)  20 (69.0)  195 (71.4)  
     Secondary  37 (28.9)  32 (27.6)  9 (31.0)  78 (28.6)  
Prior endopyelotomy:      
     Yes  27 (21.1)  25 (21.6)  9 (31.0)  61 (22.3)  
     No  101 (78.9)  91 (78.4)  20 (69.0)  212 (77.7)  
Prior pyeloplasty:      
     Yes  13 (10.2)  3 (2.6)  0 (0.0)  16 (5.9)  
     No  115 (89.8)  113 (97.4)  29 (100.0)  157 (94.1)  
Side:      
     Rt  69 (53.9)  62 (53.4)  18 (62.1)  149 (54.6)  
     Lt  59 (46.1)  54 (46.6)  11 (37.9)  124 (45.4)  
Age:      
     Younger than 41  73 (57.0)  50 (43.1)  15 (51.7)  138 (50.5)  
     41 or Older  55 (43.0)  66 (56.9)  14 (48.3)  135 (49.5)  
Success:      
     Yes  77 (60.2)  103 (88.8)  29 (100)  209 (76.6)  
     No  51 (39.8)  13 (11.2)  0 (0.0)  64 (23.4)  
* LP in 114 patients.      
† LP in 59 patients.      
 
 
 
 
 
 
 
 
 
 
 
 
 
TABLE 2. Cox regression hazard ratios  
                                                                                          All Data  Endopyelotomy Only LP Only 
                                                                    HR (95% CI)  p Value  HR (95% CI)  p Value  HR (95% CI)  p Value  
Univariable analysis:      
    Endopyelotomy vs laparoscopy  2.85 (1.54, 5.28)  0.001     
    Sex (male vs female)  0.70 (0.42, 1.18)  0.178  0.68 (0.38, 1.24)  0.211  1.01 (0.34, 3.00)  0.990  
    Crossing vessels (yes vs no)  0.75 (0.46, 1.23)  0.253  1.32 (0.76, 2.28)  0.330  0.27 (0.08, 0.87)  0.028  
    High insertion (yes vs no)  0.90 (0.54, 1.52)  0.702  0.51 (0.29, 0.88)  0.017  6.31 (1.22, 32.54)  0.028  
    Primary vs secondary repair  1.33 (0.77, 2.29)  0.315  1.36 (0.73, 2.53)  0.326  1.17 (0.36, 3.81)  0.800  
    Prior endopyelotomy (yes vs no)  0.96 (0.54, 1.72)  0.895  0.99 (0.51, 1.94)  0.988  1.13 (0.34, 3.72)  0.843  
    Prior pyeloplasty (yes vs no)  0.77 (0.31, 1.93)  0.577  0.63 (0.25, 1.59)  0.329  Not estimated  0.994  
    Side (rt vs lt)  1.18 (0.72, 1.93)  0.519  0.97 (0.56, 1.69)  0.909  2.29 (0.70, 7.44)  0.169  
    Age (younger than 41 vs 41 or older)  1.90 (1.15, 3.15)  0.012  2.01 (1.15, 3.51)  0.014  2.84 (0.78, 10.34)  0.112  
Multivariable analysis:       
    Endopyelotomy vs laparoscopy  3.16 (1.70, 5.86)  <0.001     
    Age (younger than 41 vs 41 or older)  2.15 (1.30, 3.57)  0.003  2.01 (1.15, 3.51)  0.014    
    Crossing vessels (yes vs no)      0.27 (0.08, 0.87)  0.028  
 
